ARMISTICE CAPITAL, LLC - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for BioXcel Therapeutics, Inc. (BTAI)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: BioXcel Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: BTAI
Shares outstanding: 50M shares
Disclosed Ownership: 5M shares
Ownership: 9.99%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 05:27 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	9.99%	5M	0	5M	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	9.99%	5M	0	5M	/s/ Steven Boyd	Steven Boyd